News and Announcements
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news.
Congratulations to the award recipients who celebrated with colleagues and friends on at a ceremony and reception on February 7.
Tina Mantis, an active supporter of the Hippocratic Cancer Research Foundation’s Founding Board, died February 5.
The Lurie Cancer Center is pleased to announce the first recipients of the Hippocratic Scholar Awards.
According to a recent study, Northwestern scientists have pinpointed how an ectoenzyme called CD73 undermines the effectiveness of an emerging cancer therapy.
The Presidential Leadership Scholars (PLS) program announced that Melissa Simon, MD, MPH, co-leader of the Cancer Control and Survivorship Program at the Lurie Cancer Center, was selected as one of the 60 Scholars who will form the program’s fifth annual class. PLS serves as a catalyst for a diverse network of established leaders brought together to collaborate and make a difference in the world as they learn about leadership through the lens of the presidential experiences of George W. Bush, Bill Clinton, George H.W. Bush, and Lyndon B. Johnson.
A Northwestern Medicine study has demonstrated the role of dopamine in the progression of glioblastoma and suggests that targeting the neurotransmitter may slow cancer growth.
Cancer patients can quit smoking through lengthened medication time, behavioral counseling
Betina Yanez, PhD, received the New Investigator Award 2019 from the American Psychosocial Oncology Society.
Subcutaneous fat cells in mice expanded after a gene transcription factor was deleted, according to a new study published in Cell Reports.
A Northwestern Medicine study provides new insights into a signaling pathway in metastatic prostate cancer and suggests that a novel drug combination may improve treatment response and slow cancer growth.
A new tool developed in the laboratory of Vadim Backman, PhD, can detect subtle changes for early diagnosis of disease.
Northwestern scientists have successfully transformed induced pluripotent stem cells into endometrial cells, which line the uterus and are involved in several uterine conditions such as endometrial cancer and infertility.
Molecular bioscientist Curt Horvath reveals previously unknown cellular-level reactions to viral infection. The findings could eventually help fight disease better.
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
Jonny Coffman had been battling cancer for years when a truly terrible side effect of his treatment kicked in last year: he lost his sense of taste.
A new full-body scan could help clinicians better assess patients during cancer treatment, according to a recent study.
Northwestern Medicine scientists have identified a gene, called isocitrate dehydrogenase 3-alpha, that promotes tumors in grade IV glioblastoma, according to a study published in Science Advances.
A poem by patient, Sheena Gibbs
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, the first step towards a pediatric leukemia “super drug.”
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
See more news in the article archive.